AIxSCAN Archives - Mediformatica

Pioneering AIxSCAN, Inc. introduces the ARC60, an AI-driven tomosynthesis X-ray imaging system poised to revolutionize lung disease diagnosis. Clinical trials demonstrate promising results, igniting anticipation for FDA approval in 2024. Supported by cutting-edge technology…

Neuralink receives approval to begin clinical trial in Canada on brain implant

Rightway, Curai Health partner to expand access to virtual care

A Remote Patient Monitoring System With Feedback Mechanisms Using a Smartwatch: Concept, Implementation, and Evaluation Based on the activeDCM Randomized Controlled Trial

CommonSpirit partners up with U of U for clinical collaboration

Tag: AIxSCAN

Advancing Lung Disease Diagnosis with Imaging Technology

Medical Imaging with AIxSCAN’s ARC60 Trials

Neuralink receives approval to begin clinical trial in Canada on brain implant

A Look at Epic Culture and Interoperability with Brendan Keeler – Part 1

Rightway, Curai Health partner to expand access to virtual care

A Remote Patient Monitoring System With Feedback Mechanisms Using a Smartwatch: Concept, Implementation, and Evaluation Based on the activeDCM Randomized Controlled Trial

CommonSpirit partners up with U of U for clinical collaboration

Twin Brothers Launch Seen Health with $22M to Provide Culturally-Focused Care for Seniors – MedCity News

Converge Bio raises $5.5M to expedite drug discovery, development with GenAI

Value-Based Care Is a Four Layer Cake — Why Do We Only Focus on The Icing? – MedCity News

‘A Lot More Teamwork’: Healthcare Explores the Use of AI for Nursing Workflows

Millions of Americans Still Uninsured or Underinsured Despite ACA Gains

MediFormatica

News Aggregator